Microbio Co (4128.TWO) Stock Price

Microbio Co Price

CLOSED
13.85
​
Market closed

Revenue has compounded at 11.7% per year over the past 19 years to 1.89 B TWD. Earnings per share have grown at 13.9% per year over the last 14 years. Microbio Co's net margin stands at -40.0%, down from -13.1% several years earlier. Microbio Co currently offers a dividend yield of about 0.28%.

Microbio Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Microbio Co business model & stock analysis

Microbio Co., Ltd. generates revenue through the sale of fermentation products like Tien Chun Bao (TCB) oral solutions, herbal products such as the LeeHerb series, and organic foods including vegetables, fruits, nuts, pastry, seasonings, and organic meals. The company also sells new medicines, including anticancer drugs, hepatitis treatments, allergy medications, and rheumatoid arthritis therapies. Domestic market sales form the primary distribution channel for all product lines. The firm targets consumers seeking natural health solutions through its Tien Chun Bao and LeeHerb product lines, while healthcare professionals and patients requiring specialized treatments purchase its new medicines. Organic food buyers include health-conscious individuals and households looking for sustainable dietary options. All products are sold within Taiwan's domestic market, with no international distribution mentioned. Microbio Co., Ltd. focuses on three core product segments: fermentation-based health solutions, herbal healthcare products, and organic food items. The anticancer and hepatitis medicine segments serve medical professionals and patients in Taiwan, while allergy and rheumatoid arthritis treatments target specific patient groups. The company's product portfolio is fully contained within Taiwan's domestic market, with no indication of international expansion.

Frequently asked questions about Microbio Co

Converted at the current exchange rate, the Microbio Co share trades at 0.38 EUR (13.85 TWD).

The revenue cannot currently be calculated for Microbio Co.

The profit cannot currently be calculated for Microbio Co.

The P/E ratio cannot be calculated for Microbio Co at the moment.

The P/S cannot be calculated for Microbio Co currently.

The Eulerpool Quality Score for Microbio Co is 1/10.

The ISIN of Microbio Co is TW0004128004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Microbio Co is 4128.TWO. The ticker symbol is used to trade Microbio Co shares on the stock exchange.

Fair ValueTerminal
11.50 TWD
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Care Products
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Feb 10, 2003
ISIN
TW0004128004
Cusip
Y6035R109
Market capitalization
8.15 B TWDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.91
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-8.50 %
Dividend
Dividend yield
0.00 %
Payout Ratio
12.75 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Nov 19, 2026, 3:44 AM

Microbio Co Peer Group

Microbio Co Ticker

TWO · 4128.TWO

Microbio Co FIGI

4128:TT (Taipei Stock Exchange) · BBG000PN7101

All fundamentals and in-depth analysis of Microbio Co

Our stock analysis for Microbio Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Microbio Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.